Zofran
Zofran (ondansetron) and its dissolvable sister drug Zuplenz are drugs originally developed to treat nausea in cancer patients. GlaxoSmithKline, the drug company responsible for Zofran, in an effort to capitalize on another segment of the market, encouraged the prescription of this medication for nausea in pregnant women.